ClinicalTrials.gg
RecruitingNCT06875414resilienceUpdated Mar 13, 2025

Breast Cancer and Resilience in Couple

An observational study in Breast Neoplasms and Quality of Life, sponsored by Regina Elena Cancer Institute. Recruiting at 1 site in Italy. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-13.

Sponsored by Regina Elena Cancer Institute · Observational

How we know

From the registry’s dates

  • Started Nov 2022; still recruiting 4 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Breast Neoplasms by Regina Elena Cancer Institute — 7 open to participants now, 8 under way, none of them phase 3. Breast Neoplasms · Regina Elena Cancer Institute.

Planned enrollment
10th of 11
40 · median 134
Started
2022
with 4 others
Observational
12 of 15
7 open now
Registered
6th of 15
by date

Among the 15 studies in Breast Neoplasms by Regina Elena Cancer Institute, this one is the 10th largest by planned enrollment of the 11 observational ones that give a count, is one of 5 that started in 2022, is one of 12 observational ones, and was the 6th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

7 of the 15 studies in Breast Neoplasms by Regina Elena Cancer Institute are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Breast Neoplasms by Regina Elena Cancer Institute, or all of them as a file.
02

Study summary

This is a prospective pilot study examining the couple's dyadic attitudes from diagnosis to 24 months later when one member is affected by illness and the adaptive strategies the couple employs when stressful events occur.

Read the detailed description

The patients taking part in the study and their partners are examined from the time of the woman's breast cancer diagnosis up to 24 months later with the help of questionnaires and a focus group in order to understand the couple's coping strategies.

03

Conditions studied

  • Breast Neoplasms
  • Quality of Life

Keywords

  • breast cancer
  • quality of life
  • resilience
  • depression
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of 40 couples with women affected by breast cancer who had lived together for at least six months before the diagnosis of breast cancer

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Woman diagnosed with stage 1, 2 or 3 breast cancer
  • age> 18 years (patient and partner)
  • The partner must have lived with the woman for at least 6 months at diagnosis and treatment
  • Patients under treatment at the radiotherapy clinic
  • Subjects available and able to answer questionnaires, interviews, and / or participate in focus groups

Exclusion criteria

EXCLUSION CRITERIA:

Cognitive deficits and / or inability to comply with the provisions of the study

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Couple

    The adaptation strategies that the couple uses

    Behavioral: Nursing care model

Interventions

  • BehavioralNursing care model

    Describe relation between resilience, quality of life and depression and marital adaptation in the population considered from diagnosis to 24 months later.

06

What researchers measure

Primary outcomes

  1. EORTC-QLQ C30

    The questionnaire EORTC-QLQ C30 (Kaasa, S., Bjordal, K., Aaronson, N.,1995) will evaluate the quality of life and will be administered to patients and their partners during a scheduled check-up visit at the Institute

    Time frame: 24 months

Secondary outcomes

  1. Marital Adjustment Test

    Marital Adjustment Test (Locke and Wallace, 1959), this test validated in Italian, to investigate marital satisfaction, and will be administered to patients and their partners during a scheduled check-up visit at the Institute

    Time frame: 24 months

  2. PHQ-9 Scale

    PHQ-9 Scale (Spitzer, Kroenke, Williams, 1999) validated in Italian, this questionnaire will be administered to patients and their partners during a scheduled check-up visit at the Institute to investigate psychological adjustment, in particular the presence of depression

    Time frame: 24 months

  3. Resilience Scale

    Resilience Scale (Wagnild, G. M., \& Young, H. M., 1993) validated in Italian, administered to patients and their partners during a scheduled check-up visit at the Institute to investigate resilience in adults.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Badger TA, Segrin C, Hepworth JT, Pasvogel A, Weihs K, Lopez AM. Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psychooncology. 2013 May;22(5):1035-42. doi: 10.1002/pon.3101. Epub 2012 May 10. PubMed 22573418 ↗
  • Badr H, Krebs P. A systematic review and meta-analysis of psychosocial interventions for couples coping with cancer. Psychooncology. 2013 Aug;22(8):1688-704. doi: 10.1002/pon.3200. Epub 2012 Oct 9. PubMed 23045191 ↗
  • Belcher AJ, Laurenceau JP, Graber EC, Cohen LH, Dasch KB, Siegel SD. Daily support in couples coping with early stage breast cancer: maintaining intimacy during adversity. Health Psychol. 2011 Nov;30(6):665-73. doi: 10.1037/a0024705. Epub 2011 Aug 8. PubMed 21823795 ↗
  • Bigatti SM, Steiner JL, Makinabakan N, Hernandez AM, Johnston E, Storniolo AM. Matched and mismatched cognitive appraisals in patients with breast cancer and their partners: implications for psychological distress. Psychooncology. 2012 Nov;21(11):1229-36. doi: 10.1002/pon.2028. Epub 2011 Sep 1. PubMed 21882286 ↗
  • Brandao T, Schulz MS, Matos PM. Psychological intervention with couples coping with breast cancer: a systematic review. Psychol Health. 2014;29(5):491-516. doi: 10.1080/08870446.2013.859257. Epub 2013 Nov 27. PubMed 24279379 ↗
  • Christie KM, Meyerowitz BE, Stanton AL, Rowland JH, Ganz PA. Characteristics of breast cancer survivors that predict partners' participation in research. Ann Behav Med. 2013 Aug;46(1):107-13. doi: 10.1007/s12160-013-9477-7. PubMed 23456213 ↗
  • Dalton WT 3rd, Nelson DV, Brobst JB, Lindsay JE, Friedman LC. Psychosocial variables associated with husbands' adjustment three months following wives' diagnosis of breast cancer. J Cancer Educ. 2007 Winter;22(4):245-9. doi: 10.1007/BF03174124. PubMed 18067437 ↗
  • Duggleby W, Doell H, Cooper D, Thomas R, Ghosh S. The quality of life of male spouses of women with breast cancer: hope, self-efficacy, and perceptions of guilt. Cancer Nurs. 2014 Jan-Feb;37(1):E28-35. doi: 10.1097/NCC.0b013e31827ca807. PubMed 23348665 ↗
  • Fergus KD, Gray RE. Relationship vulnerabilities during breast cancer: patient and partner perspectives. Psychooncology. 2009 Dec;18(12):1311-22. doi: 10.1002/pon.1555. PubMed 19353517 ↗
  • Hoga LA, Mello DS, Dias AF. Psychosocial perspectives of the partners of breast cancer patients treated with a mastectomy: an analysis of personal narratives. Cancer Nurs. 2008 Jul-Aug;31(4):318-25. doi: 10.1097/01.NCC.0000305748.43367.1b. PubMed 18600120 ↗
  • Hubbard G, Menzies S, Flynn P, Adams S, Haseen F, Thomas I, Scanlon K, Reed L, Forbat L. Relational mechanisms and psychological outcomes in couples affected by breast cancer: a systematic narrative analysis of the literature. BMJ Support Palliat Care. 2013 Sep;3(3):309-17. doi: 10.1136/bmjspcare-2012-000274. Epub 2012 Oct 25. PubMed 24644749 ↗
  • Jun EY, Kim S, Chang SB, Oh K, Kang HS, Kang SS. The effect of a sexual life reframing program on marital intimacy, body image, and sexual function among breast cancer survivors. Cancer Nurs. 2011 Mar-Apr;34(2):142-9. doi: 10.1097/NCC.0b013e3181f1ab7a. PubMed 20885305 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2022 to primary completion in Mar 2024, 16 months.

Of 1,193 non-industry observational studies under Breast Neoplasms, half reached primary completion within 58 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 139. This study's 16 months is below that.

Counting every sponsor, half of 1,382 studies reached it within 55 months; a quarter within 25 and three quarters within 126.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2023
First posted
Mar 13, 2025
StartActual
Nov 14, 2022
Primary completionActual
Mar 15, 2024
CompletionEst.
Nov 14, 2025
Last update
Mar 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06875414
Lead sponsor
Regina Elena Cancer Institute
Responsible party
Silvia Takanen (Doctor Principal Investigator, Regina Elena Cancer Institute) — Principal investigator
First posted
Mar 13, 2025
Start date
Nov 14, 2022
Primary completion
Mar 15, 2024
Completion
Nov 14, 2025 (estimated)
Last update
Mar 13, 2025

Study contacts

Ilaria Farina, MSN
Contact
ilaria.farina@ifo.it
0652666804
Silvia Takanen, Dr
Contact
silvia.takanen@ifo.it

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion